APG Asset Management US’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,792
Closed -$1.59M 96
2025
Q3
$1.59M Hold
4,792
0.01% 116
2025
Q2
$1.9M Hold
4,792
0.01% 106
2025
Q1
$2.07M Hold
4,792
0.02% 100
2024
Q4
$1.77M Buy
4,792
+1,752
+58% +$733K 0.01% 100
2024
Q3
$1.55M Sell
3,040
-38,368
-93% -$20.5M 0.01% 106
2024
Q2
$22.1M Buy
41,408
+658
+2% +$348K 0.13% 94
2024
Q1
$21M Buy
40,750
+9,765
+32% +$4.86M 0.12% 93
2023
Q4
$14.6M Buy
+30,985
New +$14.3M 0.09% 91

Other funds holding ELV

APG Asset Management US's ELV Position: Q4 2025 in Review

APG Asset Management US sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 4,792 shares — an estimated $1.59M sold.

APG Asset Management US first reported a position in ELV in Q4 2023 and held it in 8 quarters. The position peaked at $22.1M in Q2 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • APG Asset Management US reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 4,792 Elevance Health shares in Q4 2025, an estimated $1.59M.
  • APG Asset Management US first reported a position in Elevance Health in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Elevance Health position peaked at $22.1M in Q2 2024.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.